scholarly journals Physiological monitoring in the complex multimorbid heart failure patient - Conclusions

2019 ◽  
Vol 21 (Supplement_M) ◽  
pp. M68-M71 ◽  
Author(s):  
Michael Böhm ◽  
Andrew J S Coats ◽  
Ingrid Kindermann ◽  
Ilaria Spoletini ◽  
Giuseppe Rosano

Abstract Comorbidities are increasingly recognized as crucial components of the heart failure syndrome. Main specific challenges are polypharmacy, poor adherence to treatments, psychological aspects, and the need of monitoring after discharge. The chronic multimorbid patient therefore represents a specific heart failure phenotype that needs an appropriate and continuous management over time. This supplement issue covers the key points of a series of meeting coordinated by the Heart Failure Association of the European Society of Cardiology (ESC), that have discussed the issues surrounding the effective monitoring of our ever more complex and multimorbid heart failure patients. Here, we present an overview of the complex issues from a healthcare delivery perspective.

2019 ◽  
Vol 21 (Supplement_M) ◽  
pp. M5-M8
Author(s):  
Ilaria Spoletini ◽  
Andrew J S Coats ◽  
Michele Senni ◽  
Giuseppe M C Rosano

Abstract The role of biomarkers is increasingly recognized in heart failure (HF) management, for diagnosis, prognostication, and screening of high-risk patients. Beyond natriuretic peptides and troponins, the utility of novel, emerging biomarkers is less established. This document reflects the key points of a Heart Failure Association of the European Society of Cardiology (ESC) consensus meeting on biomarker monitoring in HF.


Sign in / Sign up

Export Citation Format

Share Document